Skip to main navigation Skip to search Skip to main content

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID

  • Jun Won Seo
  • , Seong Eun Kim
  • , Yoonjung Kim
  • , Eun Jung Kim
  • , Tark Kim
  • , Taehwa Kim
  • , So Hee Lee
  • , Eunjung Lee
  • , Jacob Lee
  • , Yu Bin Seo
  • , Young Hoon Jeong
  • , Young Hee Jung
  • , Yu Jung Choi
  • , Joon Young Song
  • Chosun University
  • Chonnam National University
  • Welfare
  • Soonchunhyang University
  • Pusan National University
  • National Medical Center
  • Hallym University
  • Chung-Ang University
  • Hanyang University
  • Korea University

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

"Long COVID"is a term used to describe a condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected with COVID-19; this condition has been reported globally and poses a serious public health issue. Long COVID can manifest in various forms, highlighting the need for appropriate evaluation and management by experts from various fields. However, due to the lack of clear clinical definitions, knowledge of pathophysiology, diagnostic methods, and treatment protocols, it is necessary to develop the best standard clinical guidelines based on the scientific evidence reported to date. We developed this clinical guideline for diagnosing and treating long COVID by analyzing the latest research data collected from the start of the COVID-19 pandemic until June 2023, along with the consensus of expert opinions. This guideline provides recommendations for diagnosis and treatment that can be applied in clinical practice, based on a total of 32 key questions related to patients with long COVID. The evaluation of patients with long COVID should be comprehensive, including medical history, physical examination, blood tests, imaging studies, and functional tests. To reduce the risk of developing long COVID, vaccination and antiviral treatment during the acute phase are recommended. This guideline will be revised when there is a reasonable need for updates based on the availability of new knowledge on the diagnosis and treatment of long COVID.

Original languageEnglish
Pages (from-to)122-157
Number of pages36
JournalInfection and Chemotherapy
Volume56
Issue number1
DOIs
StatePublished - Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Long COVID
  • Management
  • Persistent symptoms
  • Post-COVID condition
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID'. Together they form a unique fingerprint.

Cite this